1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 10 NOVEMBER 2014

World Generic Markets 10 NOVEMBER 2014

  • November 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Canadian R&D Spending Will Require Renewed Focus
Industry Trend Analysis - Sandoz Looks To Overturn Teva's Dominance
Industry Brief - Canadian Generics Agreement To Create Savings
Industry Brief - Actavis Sees US Lo Loestrin Fe Patent Victory
Industry Trend Analysis - Sutent’s US Patents Stymie Generic Challenge For Now
Industry Brief - The Medicines Company Sees US Angiomax Patent Victory
Industry Brief - Breckenridge/Natco Gain US Armodafinil Tentative Approval
Industry Trend Analysis - Mylan Determines To Pursue Redomiciling
Industry Brief - Ranbaxy Pays USD39.75mn To Settle Texas Medicaid Fraud Claim
Industry Brief - Dr Reddy’s Launches Sirolimus Tablets In US
Industry Brief - Lannett Gains US Letrozole Approval
Industry Brief - TWi Receives FDA Donepezil Approval
Industry Brief - Mylan Launches Nevirapine In US
Industry Brief - Breckenridge Reports Quetiapine Approval In US
Industry Brief - Mylan Launches Generic Loestrin 24 Fe In US
Industry Brief - Glenmark Gains US Omeprazole Approval
Industry Brief - Ranbaxy Gains US Fenofibrate Approval
Industry Brief - ANI Launches Methazolamide In US
Industry Brief - Hospira Launches Paricalcitol Injection In US
Industry Brief - Perrigo Restarts 600mg Guaifenesin Shipments
Industry Brief - Lupin Gains Celecoxib Approval And Tentative Approval
Industry Brief - Heritage’s Rifampin Injection Launched In US
Industry Brief - UCB To Sell Kremers To Private Equity Firms
Industry Brief - Perrigo To Acquire Omega Pharma
Industry Trend Analysis - Branded Acquisitions Drive Actavis Forward, But Generics Remain Important
Industry Trend Analysis - Ranbaxy Results Show Overall Strengthening As Sun Merger Approaches

Table Of Contents

World Generic Markets 10 NOVEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.